Related Experiment Video
Updated: Jun 27, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
HBEGF, SRA1, and IK: Three cosegregating genes as determinants of cardiomyopathy
Frauke Friedrichs1, Christian Zugck, Gerd-Jörg Rauch
1Division of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, Heidelberg 69120, Germany.
Insights
Genetic variations in a specific DNA region are linked to dilated cardiomyopathy (DCM), a heart muscle disorder. Reducing key genes in this region independently caused heart dysfunction in zebrafish, suggesting complex genetic causes for DCM.
Area of Science:
- Genetics
- Cardiology
- Genomics
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure and sudden cardiac death.
- Genetic factors contribute to DCM, but known variations explain only a fraction of cases.
- Current understanding often focuses on single gene defects, potentially oversimplifying complex diseases.
Purpose of the Study:
- To investigate a specific chromosomal region (5q31.2-3) associated with dilated cardiomyopathy.
- To explore the functional impact of genes within this region on cardiac function.
- To understand the evolutionary origins and conservation of this genetic region.
Main Methods:
- Genome-wide association study (GWAS) in three Caucasian populations to identify linkage disequilibrium (LD) regions associated with DCM.
- Functional studies using zebrafish morpholino knockdown to assess the impact of specific genes (HBEGF, IK, SRA1) on myocardial contractility.
- Comparative genomic analysis across vertebrate species to trace the evolutionary history of the identified LD block.
Main Results:
- A 600-kb LD region on chromosome 5q31.2-3 was significantly associated with DCM across independent populations (P = 0.00087).
- Knockdown of zebrafish orthologs for HBEGF, IK, and SRA1 independently resulted in myocardial contractile dysfunction.
- Evolutionary analysis revealed that this heart failure-associated LD block has been conserved as a cluster across mammalian genomes.
Conclusions:
- A multi-gene locus within a linkage disequilibrium block on 5q31.2-3 contributes to dilated cardiomyopathy.
- Complex genetic architectures, involving multiple genes within a haplotype, may underlie DCM pathogenesis.
- Rethinking the causality of genetic diseases requires assessing contributions beyond single-locus effects.
Abstract:
Human dilated cardiomyopathy (DCM), a disorder of the cardiac muscle, causes considerable morbidity and mortality and is one of the major causes of sudden cardiac death. Genetic factors play a role in the etiology and pathogenesis of DCM. Disease-associated genetic variations identified to date have been identified in single families or single sporadic patients and explain a minority of the etiology of DCM. We show that a 600-kb region of linkage disequilibrium (LD) on 5q31.2-3, harboring multiple genes, is associated with cardiomyopathy in three independent Caucasian populations (combined P-value = 0.00087). Functional assessment in zebrafish demonstrates that at least three genes, orthologous to loci in this LD block, HBEGF, IK, and SRA1, result independently in a phenotype of myocardial contractile dysfunction when their expression is reduced with morpholino antisense reagents. Evolutionary analysis across multiple vertebrate genomes suggests that this heart failure-associated LD block emerged by a series of genomic rearrangements across amphibian, avian, and mammalian genomes and is maintained as a cluster in mammals. Taken together, these observations challenge the simple notion that disease phenotypes can be traced to altered function of a single locus within a haplotype and suggest that a more detailed assessment of causality can be necessary.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genetic Lingo
Multiple Allele Traits
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy

